Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 727-733

  Anderson, Jeffrey L ^a,b   King, Gretchen J ^a   Bair, Tami L ^a   Elmer, Sidney P ^a   Muhlestein, Joseph B ^a   Habashi, Jessica ^a   Carlquist, John F ^a  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIIA;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BASE PAIRING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROPHORESIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DNA; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0033101664     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00603-2     Document Type: Article

References (27)

1. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIbh/IIIa complex. Blood 1988;71:831-43.
2. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994;24:1591-601.
3. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-9.
4. Fitzgerald KF, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary artery disease. N Engl J Med 1986;315:983-9.
5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
6. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549-54.
7. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
8. Simoons ML, DeBoer MJ, van den Brand MJ, et al. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. Circulation 1994;89:596-603.
9. Coller BS. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 1995;92:2373-80.
10. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
11. Gold HK, Garabedian HD, Dinsmore RE, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Circulation 1997;95:1755-9.
12. Muhlestein JB, Karagounis LA, Trehan S, Anderson JL. "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol 1997;30:1729-34.
13. The PRISM-PLUS Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
14. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
15. Kickler TS. Platelet immunology. In: Anderson KC, Ness PM, editors. Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. Philadelphia: W.B. Saunders, 1994:304-15.
16. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens PIA1 and PIA2 are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778-81.
17. Jin Y, Dietz HC, Nurden A, Bray PE. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993;82:2281-8.
18. Shulman NR, Aster RH, Leitner A, Hiller MC. Immunoreactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen: a proposed mechanism for thrombocytopenia and its relevance in "autoimmunity." J Clin Invest 1961;40:1597-620.
19. van Loghem JJ Jr, Dorfmeijer H, van der Hart M, Schreuder F. Serological and genetical studies on a platelet antigen (Zw). Vox Sang 1959;4:161-9.
20. Kunicki TJ, Aster RH. Isolation and immunologic characterization of the human platelet alloantigen, PIA1. Mol Immunol 1969;16:353-60.
21. Weiss EJ, Goldschmidt-Clermont PJ, Grigoryev D, et al. A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes alloantigens PIA1 from PIA2. Tissue Antigens 1995;46:374-81.
22. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-4.
23. Ridker PM, Hennekens CH, Schmilz C, et al. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997;349:385-8.
24. McClellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-57.
25. Marshall HW, Morrison LC, Wu LL, et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Circulation 1994;89:567-77.
26. Coronary Artery Surgery Study Principal Investigators and Their Associates. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 1984;310:750-4.
27. Carlquist JF, Ward RH, Meyer KJ, et al. Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol 1995;26:452-7.